Clopidogrel and metoprolol in myocardial infarction [2]

Lancet

Volumn 367, Issue 9513, 2006, Pages 811-812

  Borja, Javier ^a   García, Olga ^a   Donado, Esther ^a   Izquierdo, Iñaki ^a  

^a J Uriach y Compania   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; METOPROLOL; PLACEBO;

ABSENCE OF SIDE EFFECTS; ACUTE HEART INFARCTION; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; LETTER; LUNG CONGESTION; LUNG EDEMA; MEDICAL ETHICS; PRIORITY JOURNAL; TACHYCARDIA;

EID: 33644847771     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68327-X     Document Type: Letter

References (4)

1. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
2. T Killip 3rd, JT Kimball Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients Am J Cardiol 20 1967 457 464
3. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary Circulation 110 2004 588 636
4. The Task Force on Acute Heart Failure of the European Society of Cardiology Executive summary of the guidelines on the diagnosis and treatment of acute heart failure Eur Heart J 26 2005 384 416